TP53 and ovarian carcinoma: No significant differences were noted in the plasma levels of each of the 17 cytokines or CA-125 in ovarian carcinoma patients with wild type p53 versus mutated p53, with the exception of IL6 (P = .02) and IL10 (P = .007) that were significantly higher in the sera of those with mutated p53.